Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
Crossref DOI link: https://doi.org/10.1186/s12967-017-1219-3
Published Online: 2017-05-26
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Escribà-Garcia, Laura
Alvarez-Fernández, Carmen
Tellez-Gabriel, Marta
Sierra, Jorge
Briones, Javier
Funding for this research was provided by:
Fundación Cellex
AGAUR (2014SRG-1281)
Instituto de Salud Carlos III (PI15/01383)